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IN SALT-SENSITIVE, i.e., Dahl salt-sensitive (S) rats and spontaneously hypertensive rats (SHR), high salt intake increases cerebrospinal fluid (CSF) Na ϩ concentration ([Na ϩ ]) by 4 -6 mmol/l, which appears to contribute to the development of sympathetic hyperactivity and hypertension (21, 22) . Intracerebroventricular (icv) infusion of Na ϩ -rich artificial CSF (aCSF), increasing CSF [Na ϩ ] by 5-7 mmol/l, increases blood pressure (BP) by ϳ15 mmHg in Wistar rats and by ϳ35 mmHg in Dahl S rats (22, 40) . These increases in BP can be prevented by icv infusion of spironolactone to block mineralocorticoid receptors (MR) (20) or infusion of benzamil to block, presumably, epithelial Na ϩ channels (ENaC) (40) , suggesting that MR and ENaC play an important role in the pressor responses to an increase in CSF [Na ϩ ]. ENaC is composed of three homologous subunits (␣, ␤, and ␥), which share ϳ30 -35% sequence identity (9) . All three ENaC subunits and MR are colocalized in the supraoptic nucleus, paraventricular nucleus, and subfornical organ, as well as in the choroid plexus and ependyma of the anteroventral third ventricle (3) . Regulators of ENaC expression and activity, such as aldosterone, serum/glucocorticoidinducible kinase 1 (Sgk1), and neural precursor cells expressed developmentally downregulated 4-like gene (Nedd4L), previously named Nedd4-2 in rats, are also present in the rat brain (4, 7, 24) . Sgk1 acts at multiple levels to regulate ENaC expression and activity. In the kidney, Sgk1 is activated by phosphorylation, and phosphorylated Sgk1 increases ␣-ENaC transcription (42) and enhances ENaC surface expression by phosphorylation of Nedd4L, a ubiquitin-protein ligase (11) . Phosphorylation of Nedd4L disrupts the interaction between channel and ligase and, therefore, decreases channel internalization and degradation. In addition, phosphorylated Sgk1 may physically interact with ENaC by phosphorylating the COOH terminus of ␣-ENaC, resulting in increased channel open probability (14) .
In Wistar rats, icv infusion of Na ϩ -rich aCSF increases hypothalamic aldosterone and BP, which can be prevented by icv infusion of an aldosterone synthase inhibitor, suggesting that locally produced aldosterone mediates the central actions of Na ϩ (23) . In the rat, 11␤-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) convert 11-deoxycorticosterone to corticosterone and aldosterone, respectively. The transcripts of CYP11B1 and CYP11B2 can be detected in the brain, although the levels are much lower (ϳ100-to 1,000-fold) in the central nervous system than in the adrenal gland (28) .
To test the hypothesis that Na ϩ upregulates ENaC in the brain and ENaC contributes to regulation of Na ϩ homeostasis, we assessed in Wistar rats 1) effects of central infusion of Na ϩ -rich aCSF on ENaC expression by measuring mRNA and protein abundance and subcellular distribution of ENaC subunits in the epithelial cells of the ependyma and choroid plexus, as well as in neurons of hypothalamic nuclei, 2) effects of central infusion of Na ϩ -rich aCSF on mRNA levels of ENaC regulatory genes, such as MR, Sgk1 (and protein levels), and Nedd4L, as well as CYP11B1 and CYP11B2, 3) whether blockade of MR by spironolactone prevents increases in ENaC expression, and 4) whether icv infusion of benzamil influences the increase in hypothalamic tissue and CSF [Na ϩ ] by Na ϩ -rich aCSF.
MATERIALS AND METHODS
Male Wistar rats (150 -200 g body wt; Charles River, Montreal, PQ, Canada) were housed under standard conditions (12:12-h lightdark cycle, 23 Ϯ 2°C ambient temperature). After arrival, rats received standard laboratory chow and tap water ad libitum for 5 days for acclimatization before entering the study. All procedures were carried out in accordance with the guidelines of the Canadian Council on Animal Care, which conform to National Institutes of Health guidelines and were approved by the University of Ottawa Animal Care Committee. All surgery was performed under isoflurane anes-thesia. (For details of biochemical and molecular biological techniques, see supplemental material in the online version of this article.)
Experimental Protocols
Protocol 1: biochemistry and molecular biology measurements. Two experiments were performed. In the first experiment, two sets of five groups of Wistar rats were studied for real-time quantitative RT-PCR (n ϭ 6/group) and immunohistochemistry (n ϭ 4/group), respectively. An icv cannula was implanted into the left lateral cerebral ventricle and connected to an osmotic minipump (model 2ML2, Alzet) for chronic infusion at 5 l/h for 14 days. Because the secretion rate of CSF in rats is 120 -320 l/h (10), this low rate of icv infusion is unlikely to affect CSF pressure. Rats were randomized to the following groups: 1) aCSF ([Na ϩ ] ϭ 145 mmol/l), 2) aCSF ϩ spironolactone (100 ng/h), 3) Na ϩ -rich aCSF ([Na ϩ ] ϭ 800 mmol/l), or 4) Na ϩ -rich aCSF ϩ spironolactone. In one control group, an icv cannula was not implanted. In Wistar rats, icv infusion of Na ϩ -rich aCSF at this concentration and rate of infusion for 1-2 wk increases CSF [Na ϩ ] by 5-7 mmol/l, sympathetic activity, and BP by 15 mmHg. Concomitant infusion of spironolactone (or benzamil, as in protocol 2) at the rates used in the present study prevents the increases in sympathetic activity and BP (20, 40) . In the second experiment, three sets of two groups of rats received icv infusion of aCSF or Na ϩ -rich aCSF, and Western blot analysis (n ϭ 4 -5/group) was performed, cellular localization was studied by in situ hybridization (n ϭ 4 -5/group), and subcellular localization was studied by immunoelectron microscopy (n ϭ 3/group). All rats remained on a regularsalt diet and had access to normal tap water. Abundance of mRNA for CYP11B1, CYP11B2, MR, and Nedd4L and mRNA and protein levels of ENaC and Sgk1 were evaluated in the choroid plexus, ependyma, supraoptic nucleus, paraventricular nucleus, and subfornical organ. Subcellular distribution of ENaC subunits was assessed in the choroid plexus and ependyma. To eliminate a possible effect of the icv cannula per se, the choroid plexus was obtained from the lateral ventricle opposite the infusion site. The ependyma was obtained in the area of the anteroventral third ventricle. Assessment of ENaC subunit transcripts was attempted by laser capture microscopy and real-time PCR, but the mRNA abundance was too low to be detected, and only immunohistochemistry and immunoelectron microscopy were used for evaluation of ENaC in the ependyma. The extracts from the whole supraoptic nucleus, paraventricular nucleus, and subfornical organ were studied for mRNA and protein.
Protocol 2: tissue and CSF [Na ϩ ] measurements. In the first experiment, icv cannulas were implanted in two groups of rats. The cannulas were connected to osmotic minipumps for 1 wk of icv infusion of aCSF ϩ vehicle or aCSF ϩ benzamil (4 g·kg Ϫ1 ·h Ϫ1 in vehicle, n ϭ 5/group). In a second experiment, in four groups of rats, the icv cannulas were connected to osmotic minipumps for 2 wk of icv infusion of 1) aCSF ϩ vehicle, 2) aCSF ϩ benzamil, 3) Na ϩ -rich aCSF ϩ vehicle, or 4) Na ϩ -rich aCSF ϩ benzamil (n ϭ 6 -7/group). Benzamil was dissolved in 15% propylene glycol. At the end of each of these two experiments, under halothane anesthesia, each rat was placed in a stereotaxic frame, and 100 -200 l of CSF sample were withdrawn from the cisterna magna, as described previously (21) . Rats were then decapitated, and brains were collected and stored at Ϫ80°C.
Real-Time Quantitative RT-PCR
RNA was isolated from brain punches of specific nuclei using TRIzol reagent (Invitrogen, Burlington, ON, Canada), and cDNA was synthesized using the QuantiTect reverse transcription kit with elimination of genomic DNA (Qiagen, Mississauga, ON, Canada). Realtime PCR was performed in duplicate using a LightCycler and Fast-start DNA Master SYBR Green I dye (Roche Diagnostics, Laval, QC, Canada). Phosphoglycerate kinase 1 (PGK1) was used as the housekeeping gene. (Sequences of the specific primers are described in supplemental Table S1 .)
In Situ Hybridization
The 429-bp PCR product of ␣-ENaC was subcloned into pCRII-TA cloning vector (Invitrogen). A nonradioactive digoxigenin (DIG) RNA labeling kit (Roche Diagnostics) was used to synthesize antisense and sense DIG-labeled RNA probes for ␣-ENaC using SP6 and T7 RNA polymerase (Roche Diagnostics), respectively. The hybridization was performed on 7-m-thick coronal brain sections with sense and antisense DIG-labeled RNA probes at 42°C for 16 h. Semiquantification was performed using Image Pro software version 4.02.03.
Immunohistochemistry and Immunoelectron Microscopy
Protein expression in different brain areas was studied by immunohistochemical staining of 5-m coronal sections. The slides were incubated with primary antibodies against ␣-, ␤-, and ␥-ENaC (29) and developed with Vectastain Elite ABC and diaminobenzidine kits (Vector Laboratories, Burlington, ON, Canada).
Immunoelectron microscopy was done to assess the subcellular distribution of ENaC subunits in select sections from the choroid plexus and ependyma. After incubation with the primary antibodies against ENaC subunits, 15-nm gold particle-conjugated secondary antibodies (EY Laboratories, San Mateo, CA) were used to demarcate subcellular localization of the proteins. The gold-labeled particles in each subcellular compartment were counted manually in a blinded fashion and are expressed as number per 100 m 2 .
Western Blotting
Antibodies against Sgk1 (GeneX, Hayward, CA) and phosphorylated Sgk1 (p-Sgk1:Thr 256 , Santa Cruz Biotechnology, Santa Cruz, CA) were used for immunoblotting on 40 g of protein from brain punches of the supraoptic and paraventricular nuclei.
CSF and Tissue [Na ϩ ] Assessment
CSF [Na ϩ ] and [Na ϩ ] in the hypothalamus were measured using an ion-selective electrode (model MI-425, Microelectrodes, Bedford, NH). Briefly, aCSF was prepared without NaCl; then NaCl was added to yield standards ranging from 120 to 180 mmol/l at 5 mmol/l increments for the CSF [Na ϩ ] assay. For hypothalamic [Na ϩ ], each hypothalamus was dissected, weighed, and placed in a disposable polypropylene cryovial with 500 l of HNO3 (OmniTrace Ultra High Purity Grade, EMD) on ice, and then 100 l of H2O2 (Suprapur Grade, EMD) were added. After the contents were gently mixed, the tubes were capped and left for 72 h at room temperature for digestion of the tissue (16) . After neutralization with NH 4OH (OmniTrace Ultra, EMD), sample volume was adjusted with double-distilled H2O to 5 ml in acid-washed glass volumetric flasks. Standards ranging from 0.1 to 5 mmol/l were prepared in a similar mixture of HNO3, H2O2, and NH4OH in double-distilled H2O for the tissue assay. The electrode was connected to a standard pH meter (VWR, West Chester, PA), and relative millivolt readings were recorded for the standards and samples. Log standard [Na ϩ ] was plotted against the relative millivolt readings, and unknowns were calculated from the appropriate standard curve.
Statistical Analysis
Data are expressed as means Ϯ SE. Two-way ANOVA was used to analyze data with four groups involving two factors for real-time PCR, immunohistochemistry, and for CSF and tissue [Na ϩ ]. F values from the two-way ANOVA are provided to summarize the main effects of the two factors and their interaction. When the F value was significant for an interaction effect, Student-Newman-Keuls test was performed as post hoc test for multiple comparisons. Student's t-test was performed to analyze data with two groups for in situ hybridization, Western blot analysis, and immunoelectron microscopy. Statistical significance was defined as P Ͻ 0.05.
RESULTS
Real-time quantitative RT-PCR (qPCR) analysis showed that icv infusion of control aCSF did not affect mRNA abundance of the three ENaC subunits, MR, Sgk1, or Nedd4L in different brain areas compared with values in rats without an icv infusion (data not shown). Immunohistochemistry analysis showed appreciable levels of ␣-, ␤-, and ␥-ENaC immunostaining in the choroid plexus of rats without an icv cannula and icv infusion (see supplemental Fig. S1 ). Although icv infusion of aCSF per se did not affect immunostaining for ␣-and ␤-ENaC, it decreased immunoreactivity of ␥-ENaC to low levels in all areas (see supplemental Fig. S1 for choroid plexus) and could not be reliably quantified.
Choroid Plexus
Icv infusion of Na ϩ -rich aCSF did not affect mRNA levels of ␣-and ␥-ENaC measured by qPCR (Table 1) . Immunohistochemistry showed that icv infusion of Na ϩ -rich aCSF also had no effect on percent staining of ␣-ENaC (Fig. 1A) . Na ϩ -rich aCSF infusion increased ␤-ENaC mRNA abundance by approximately twofold (P Ͻ 0.05; Table 1 ) and percent staining by 50% (P Ͻ 0.005; Fig. 1A ). Spironolactone did not significantly change ␣-ENaC mRNA levels (see supplemental  Table S2 ) but decreased percent staining for immunoreactivity in the Na ϩ -rich aCSF group (P Ͻ 0.05; Fig. 1A ). Spironolactone had no effect on the increase in ␤-ENaC mRNA abundance (see supplemental Table S2 ) but prevented the increase in percent staining of ␤-ENaC (Fig. 1A) . Spironolactone did not affect ␥-ENaC mRNA levels (see supplemental Table S2 ).
To study the localization of ENaC transcripts, ␣-ENaC was assessed by in situ hybridization, because the ␣-subunit showed the highest mRNA levels (Table 1) . Positive signals specific for ␣-subunit antisense riboprobes were more prominent in the choroid plexus cells than endothelia of blood vessels. Sense riboprobes failed to generate obviously detectable signals (see supplemental Fig. S2 ).
Immunohistochemistry ( Fig. 1A ) and immunoelectron microscopy (Fig. 1B, Table 2 ) showed that ENaC was most prominent in the cytoplasm, as well as in the apical membranes, and was present to a lesser extent in the basolateral membranes. Immunoelectron microscopy indicated that Na ϩ -rich aCSF increased the number of ␣-ENaC-gold-labeled particles, especially in the microvilli, by approximately fourfold (Fig. 1B, Table 2 ) and did not significantly (P ϭ 0.07) affect ␣-ENaC-gold-labeled particles in the basal membrane. Na ϩ -rich aCSF also increased (P Ͻ 0.05) ␤-ENaC-gold-labeled particles in the apical membrane (Table 2) . No significant effects of Na ϩ -rich aCSF on the ␥-subunits were noted ( Table 2) . Na ϩ -rich aCSF did not affect the mRNA abundance of CYP11B1, MR, Sgk1, or Nedd4L (Table 1) . CYP11B2 transcripts were below the detection limit in the choroid plexus.
Ependyma
In the ependyma of the anteroventral third ventricle, ENaC immunoreactivity was present in the cytoplasm, as well as in the apical and basal membranes of the epithelial 
Values are means Ϯ SE (n ϭ 6/group). Whole nuclei were punched from the brain and homogenized for total RNA extraction. ENaC, epithelial Na ϩ channel; aCSF, artificial cerebrospinal fluid; MR, mineralocorticoid receptor; PGK1, phosphoglycerate kinase 1; BD, below detection. By 2-way ANOVA, spironolactone had no significant effect and there were no interaction effects on any of the expression levels. Only data from the 2 groups without spironolactone are shown. (See supplemental table for data from all groups, i.e., aCSF or Na ϩ -rich aCSF with or without spironolactone.) By 2-way ANOVA for the 4 groups, there is a significant effect of Na ϩ -rich aCSF on ␤ϪENaC mRNA levels (F ϭ 5.15, *P Ͻ 0.05 vs. aCSF groups) with no effect of spironolactone on this increase (see supplemental Table S2 ). lining ( Fig. 2A) . Electron microscopy showed that ENaC particles were prominent in the cytoplasm, with similar or lesser numbers in the apical and basal membranes ( Table 2 , Fig. 2B ). By immunohistochemistry, Na ϩ -rich aCSF increased percent staining for ␣-ENaC (P Ͻ 0.0001) and ␤-ENaC (P Ͻ 0.05) immunoreactivities by ϳ30% (Fig. 2A) . Spironolactone had no effect on the increase in ␣-ENaC but lowered percent staining of ␤-ENaC in the CSF and Na ϩ -rich aCSF groups (P Ͻ 0.005; Fig. 2A ). Electron microscopy showed that Na ϩ -rich aCSF significantly increased the number of ␣-and ␤-ENaC-gold-labeled particles in the basolateral membranes and the number of ␥-ENaC-gold-labeled particles in the cytoplasm (Table 2, Fig. 2B ).
Supraoptic Nucleus
In situ hybridization showed more abundant expression of ␣-ENaC transcripts in magnocellular neurons than adjacent glial cells (see supplemental Fig. S3 ). Immunoreactivity of ENaC subunits was most prominent in the cytoplasm of the magnocellular neurons. qPCR showed that icv infusion of Na ϩ -rich aCSF did not alter mRNA abundance of ␣-, ␤-, or ␥-ENaC (Table 1) . Consistent with the PCR data, Na ϩ -rich aCSF did not affect staining for ␣-ENaC transcription, as measured by in situ hybridization, in the magnocellular neurons of the supraoptic nucleus (see supplemental Fig. S4 ). There was also no effect of Na ϩ -rich aCSF on staining for ␣-or ␤-ENaC immunoreactivity, as measured by immunohistochemistry (Fig. 3A) . 
Na
ϩ -rich aCSF did not affect Sgk1 mRNA levels ( Table 1) . Western blot analysis indicated that Na ϩ -rich aCSF did not significantly (P ϭ 0.08) affect phosphorylated Sgk1 or total Sgk1 protein levels in the supraoptic nucleus (Fig. 3B) . Na ϩ -rich aCSF did not alter CYP11B1, CYP11B2, MR, or Nedd4L mRNA levels (Table 1) .
Paraventricular Nucleus
By in situ hybridization, the staining of ␣-ENaC transcripts was more abundant in magnocellular than in parvocellular neurons (see supplemental Fig. S5 ). Immunoreactivity of ENaC subunits was more abundant in the cytoplasm of magnocellular neurons 
Values are means Ϯ SE, expressed as number of gold particles per 100 m 2 . Na ϩ , Na ϩ -rich aCSF. *Ͼ3-fold change in response to Na ϩ -rich aCSF infusion. http://ajpregu.physiology.org/ than in adjacent glial cells. Almost no immunoreactivity for ENaC subunits was noted in the parvocellular neurons. Na ϩ -rich aCSF did not alter the mRNA abundance of ENaC subunits in the whole paraventricular nucleus, as measured by qPCR (Table 1 ) or in situ hybridization (see supplemental Fig. S5 ). Immunohistochemistry showed that Na ϩ -rich aCSF also did not affect immunoreactive staining for ␣-or ␤-subunits in the magnocellular neurons of the paraventricular nucleus (Fig. 4A) . Na ϩ -rich aCSF did not affect Sgk1 mRNA levels (Table 1 ) but appeared to decrease (P ϭ 0.05) phosphorylated Sgk1 without significantly (P ϭ 0.08) altering total Sgk1 protein abundance, as shown by Western blotting (Fig. 4B) . Na ϩ -rich aCSF had no effect on the mRNA abundance of CYP11B1, CYP11B2, MR, or Nedd4L (Table 1) .
Subfornical Organ
mRNA of all three ENaC subunits was found in the subfornical organ. Immunoreactivity for ENaC subunits was diffuse in the cytoplasm of neurons in this nucleus and very low for ␣-ENaC (data not shown). Na ϩ -rich aCSF infusion did not affect mRNA levels of the three ENaC subunits (Table 1) or percent staining for ␣-or ␤-ENaC immunoreactivity (data not shown). Na ϩ -rich aCSF did not affect mRNA abundance of CYP11B1 and CYP11B2, MR, Sgk1, or Nedd4L (Table 1) .
CSF and Hypothalamic Tissue [Na ϩ ]
In rats infused icv with control aCSF ϩ benzamil, CSF [Na ϩ ] increased (P Ͻ 0.005) similarly after 1 and 2 wk (Fig. 5, top) . CSF [Na ϩ ] significantly (P Ͻ 0.05) increased to 160 Ϯ 2 mmol/l in rats infused icv with Na ϩ -rich aCSF and to 166 Ϯ 6 mmol/l (nonsignificant vs. Na ϩ -rich aCSF alone) in rats infused icv with Na ϩ -rich aCSF ϩ benzamil (Fig. 5, top) . In contrast to its effects on CSF [Na ϩ ], icv infusion of benzamil significantly (P Ͻ 0.005) lowered hypothalamic tissue [Na ϩ ] (Fig. 5, bottom) , whereas hypothalamic tissue [Na ϩ ] for the two levels of Na ϩ in the aCSF did not differ significantly, and treatment ϫ Na ϩ interaction only showed a tendency (P ϭ 0.08).
DISCUSSION
The main new findings of the present study are that, in Wistar rats, chronic icv infusion of Na ϩ -rich aCSF increases ␤-ENaC mRNA and immunoreactivity in the choroid plexus and ␣-and ␤-ENaC immunoreactivities in the ependyma. Icv infusion of Na ϩ -rich aCSF increases ␣-and ␤-ENaC particles in the apical microvilli of the choroid plexus and in the basolateral membrane of the ependyma. In contrast, Na ϩ -rich aCSF has no effect on ENaC expression in the supraoptic nucleus, paraventricular nucleus, and subfornical organ. Blockade of ENaC by icv infusion of benzamil increases CSF [Na ϩ ] in rats infused icv with aCSF but lowers hypothalamic [Na ϩ ].
CSF [Na ϩ ] and ENaC Expression in the Brain
In Dahl S rats and SHR, high salt intake increases CSF [Na ϩ ] (21, 22) . It is well established that an increase in CSF [Na ϩ ] per se, by icv infusion of Na ϩ -rich aCSF, causes sympathetic hyperactivity and hypertension (8, 22, 23, 26) . In this experimental approach, icv infusion of Na ϩ -rich aCSF does not affect plasma [Na ϩ ] (8, 18) and tends to increase water intake (18, 24) . There is functional evidence that the sympathoexcitatory and pressor responses to CSF [Na 
Choroid Plexus
In the brain ventricles, the epithelial cells of the choroid plexus are the major site for the production of CSF (6). The CSF is not an ultrafiltrate of the plasma but is actively secreted by the choroid plexus. The epithelium of the choroid plexus mediates the secretion of Na ϩ , Cl Ϫ , and HCO 3 Ϫ into the CSF, as well as the net absorption of K ϩ from the CSF into the blood (6). Na ϩ -K ϩ -ATPase is located in the apical membrane of choroid plexus cells and plays a pivotal role in the active ouabain-sensitive transport of Na ϩ from epithelial cells to CSF and of K ϩ from CSF to choroid plexus cells (6, 30) . We recently showed by electron microscopy that ENaC is located in the apical and basolateral membranes of choroid plexus cells, with a greater number of ENaC subunits on the microvilli than on the basolateral membrane (2) . This pattern of localization is similar to that in the ciliary body of the rat eye (31) and suggests that ENaC may contribute to Na ϩ influx into choroid plexus cells from the CSF and the blood, with influx of Na ϩ from the CSF into choroid epithelial cells possibly dominating. Indeed, in control (aCSF) rats, icv infusion of benzamil increased CSF [Na ϩ ] by 8 mmol/l, suggesting that ENaC plays a major role in Na ϩ reuptake from the CSF. Consistent with this concept, in the present study, a chronic increase in CSF [Na ϩ ] increased ␣-and ␤-ENaC particles, particularly in the apical membranes of the choroid plexus cells at the CSF side. The increase in ␣-ENaC particles in the microvilli may reflect enhanced protein trafficking or posttranscriptional or posttranslational regulation in the choroid plexus, because the abundance of ␣-ENaC mRNA did not change. Conversely, for ␤-ENaC, mRNA and protein abundance increased, suggesting that enhanced gene expression and de novo protein synthesis contributed. Taking these results together, one may speculate that an increase in CSF [Na ϩ ] may further enhance Na ϩ entry from the CSF side into the choroid plexus by increasing ␣-and ␤-ENaC particles in the microvilli of the choroid plexus. However, in contrast to its effects in control rats, in rats infused with Na ϩ -rich aCSF, blockade of ENaC with icv infusion of benzamil did not cause a significant further increase in CSF [Na ϩ ] (Fig. 6 ), suggesting that, in this setting, other factors may play a role. For example, inhibition of Na ϩ efflux from the choroid plexus into the CSF by inhibition of the Na ϩ pump (21) may have increased intracellular Na ϩ (2), thereby decreasing Na ϩ influx via ENaC. The mechanisms involved in regulation of ENaC in the choroid plexus have not yet been studied. Classically, the aldosterone-MR-Sgk1 pathway is a major regulator of ENaC expression and trafficking in peripheral epithelial cells (35) . In the kidney, aldosterone increases ␣-ENaC surface expression and activity via MR by increasing ␣-ENaC mRNA, and it may regulate ENaC trafficking independent of MR (5, 29, 33) . In the colon, aldosterone upregulates transcription of ␤-and ␥-ENaC, but not ␣-ENaC (1). These findings indicate that, in transport epithelia in the periphery, MR activation differentially regulates expression of ENaC subunits in a tissue-specific manner. MR are present in the choroid plexus, and MR mRNA was not affected by Na ϩ -rich aCSF. Expression of the CYP11B2 gene encoding for aldosterone synthase in the choroid plexus cells could not be substantiated. Icv infusion of Na ϩ -rich aCSF does not alter plasma aldosterone but increases hypothalamic aldosterone (20) , and this aldosterone may, via the CSF, bind MR in choroid plexus cells and, possibly, contribute to the regulation of ENaC by Na ϩ -rich aCSF. In the present study, Na ϩ -rich aCSF increased ␣-ENaC particles without altering ␣-ENaC mRNA and immunoreactivity in the choroid plexus. Concomitant infusion of spironolactone did not affect ␣-ENaC mRNA but lowered ␣-ENaC immunostaining in the Na ϩ -rich aCSF-treated group. Na ϩ -rich aCSF increased ␤-ENaC mRNA and immunoreactivity and did not affect ␥-ENaC mRNA in the choroid plexus. Spironolactone did not affect the increase in ␤-ENaC mRNA but prevented the in- 13, *P Ͻ 0.005 vs. aCSF ϩ vehicle (Veh) groups], with no significant difference between 1 and 2 wk of benzamil treatment in control aCSF-treated groups. Na ϩ -rich aCSF significantly increases CSF [Na ϩ ] (F ϭ 7.65, *P Ͻ 0.05 vs. aCSF ϩ Veh groups). Benzamil has no significant (F ϭ 3.60, P ϭ 0.07) effect on this increase in CSF [Na ϩ ]. For hypothalamic tissue [Na ϩ ], benzamil has a significant effect on tissue [Na ϩ ] (F ϭ 10.27, *P Ͻ 0.005 vs. groups without benzamil), whereas tissue [Na ϩ ] for different levels of Na ϩ in aCSF did not differ significantly (P ϭ 0.12), and treatment ϫ Na ϩ interaction only showed a tendency (P ϭ 0.08).
crease in protein by Na ϩ -rich aCSF. These findings suggest that the regulation of ENaC subunits in the choroid plexus by an increase in CSF [Na ϩ ] is quite unique and may involve several mechanisms, one of which is posttranscriptional regulation via MR. The effect of spironolactone on ␣-and ␤-ENaC immunostaining is consistent with MR blockade. Alternatively, its anti-androgen property could play a role. In the kidney of male Wistar rats, testosterone significantly upregulates ␣-ENaC mRNA through androgen receptors (36) , but no change in mRNA was noted in the present study. Regarding other mechanisms, vasopressin may play a role. In the kidney, chronic infusion of a vasopressin V 2 receptor agonist or water restriction markedly increases abundances of ␤-and ␥-ENaC mRNA (32) . Vasopressin and vasopressin V 1b receptor transcripts are found in the choroid plexus (41) . Vasopressin may also be released from the hypothalamus into the CSF to act on vasopressin V 1 receptors in the choroid plexus. Vasopressin expression increased 10-fold in the choroid plexus and hypothalamus of Sprague-Dawley rats after 5 days of 2% NaCl in drinking water, with an increase in CSF osmolality from 295 to 309 mosmol/kgH 2 O (37). The 10 mmol/l [Na ϩ ] increase by icv infusion of Na ϩ -rich aCSF increases osmolality by 24 mosmol/ kgH 2 O, and a resulting vasopressin release may contribute to the upregulation of ␤-ENaC expression.
Ependyma
The ependyma is a layer of specialized cells lining the wall of the brain's ventricles. The ependymal cells are interconnected by gap junctions and may facilitate diffusion of K ϩ from the extracellular space of the hypothalamus (7, 12, 25) . Whether the ependyma actively regulates [Na ϩ ] in the interstitial space has not been studied. In ependymal cells in the area of the anteroventral third ventricle, the higher abundance of ENaC subunits on the apical than on the basolateral membranes is suggestive of net transport of Na ϩ from CSF into brain tissue (Fig. 6) (Fig. 6) . Regarding the mechanisms involved in regulation of ENaC in the ependyma, spironolactone did not prevent the increase in immunoreactivity of ␣-ENaC but lowered immunoreactivity of ␤-ENaC in the aCSF-and Na ϩ -rich aCSF-treated groups. The ependyma and choroid plexus may therefore show posttranscriptional regulation via MR as one of several mechanisms involved in regulation of ENaC subunits by CSF [Na ϩ ].
Hypothalamic Nuclei
The supraoptic nucleus, paraventricular nucleus, and subfornical organ, representing three important nuclei involved in different aspects of signaling in response to an increase in CSF and tissue [Na ϩ ], were studied. Central infusion of an MR blocker or benzamil prevents the increase in hypothalamic "ouabain" and the sympathoexcitatory and pressor responses to an increase in CSF [Na ϩ ] or aldosterone (20, 40) . It is not clear where in the hypothalamus the MR-and benzamil-sensitive Na ϩ channels involved in these responses are located, and studies in specific nuclei may give further insights in this regard. Located within close proximity to the ependyma of the third ventricle, Na ϩ -sensitive neurons in the subfornical organ may sense changes in CSF [Na ϩ ] and project to the paraventricular nucleus and supraoptic nucleus (13, 34) , possibly leading to production of aldosterone in magnocellular neurons (23, 38) . In the present study, the transcription of aldosterone synthase or 11␤-hydroxylase was not affected by Na ϩ -rich aCSF in these three nuclei, but enzymatic activity was not assessed. Icv infusion of Na ϩ -rich aCSF increases hypothalamic aldosterone and corticosterone content (23) , suggesting that the regulation of aldosterone and corticosterone production by Na ϩ may involve early steps in the steroid biosynthetic pathway.
In situ hybridization and immunohistochemistry show that ENaC transcripts and protein are most prominent in the magnocellular neurons of the paraventricular nucleus and supraoptic nucleus. ENaC in these neurons may possibly mediate aldosterone-induced increases in "ouabain," which can be blocked by benzamil (39) . However, in contrast to brain epithelial cells, Na ϩ -rich aCSF infusion did not alter ENaC mRNA and protein expression in either nucleus. Subcellular distribution of ENaC in response to Na ϩ -rich aCSF infusion was not evaluated. mRNA levels of MR, Sgk1, and Nedd4L were also unaffected by Na ϩ -rich aCSF. Phosphorylated Sgk1 tended to be decreased by Na ϩ -rich aCSF. Such a decrease may lower membrane channel abundance and activity (35) . The functional relevance of these findings requires further studies.
Limitations of the Study
Several possible limitations should be considered. First, direct measures of ENaC activity were not obtained in the present study. The effects of benzamil on CSF and hypothalamic tissue [Na ϩ ] may suggest that the changes in one or two ENaC subunits are indeed associated with parallel changes in ENaC activity in the choroid plexus or ependyma. The infusion rate of 4 g·kg Ϫ1 ·day Ϫ1 is similar to that used by others (18) . For a baseline CSF production rate of ϳ6 ml/day and total CSF volume of ϳ0.5 ml in ϳ250-to 300-g rats (19) , icv infusion of benzamil at 4 g·kg Ϫ1 ·day Ϫ1 would result in a concentration of ϳ10 mol/l in the CSF, but likely a factor lower, since benzamil will also distribute into brain tissue. Thus, one may expect maximal inhibition of ENaC, but inhibition of other Na ϩ channels or transporters cannot be excluded (27) . Second, icv infusion of Na ϩ -rich aCSF increased osmolality by 24 mosmol/kgH 2 O, which may influence expression of ENaC subunits in the brain epithelial cells. A control group for osmolality was not included, and further studies are obviously required to evaluate whether a local increase in osmolality influences ENaC expression in the brain.
Third, icv cannula and infusion of control aCSF per se did not change ␥-ENaC mRNA but decreased ␥-ENaC immunoreactivity to low levels in the choroid plexus, as well as other brain areas. Immunoreactivity to ␣-and ␤-ENaC was not affected, and immunoelectron microscopy showed that abundance of ␥-and ␤-ENaC particles was comparable. The decrease in ␥-ENaC immunoreactivity by icv infusion of aCSF may reflect a change in the ␥-ENaC protein that affects its immunoreactivity, rather than a decrease in the protein levels.
Perspectives and Significance
All three ENaC subunits are distributed on apical and basal membranes of choroid plexus and ependymal cells. This pattern of localization is quite unique compared with renal tubule or colon epithelial cells, where ENaC is only present in the apical membrane at the luminal surface (15) . In the brain, regulation of CSF and brain interstitium [Na ϩ ] cannot depend on parallel changes in water transport and may require movement of Na ϩ via ENaC in either direction. When CSF [Na ϩ ] increases, enhanced ␣-and ␤-ENaC in the apical microvilli of the choroid plexus may facilitate Na ϩ entry into the choroid plexus cells from the CSF. Similarly, when hypothalamic tissue [Na ϩ ] increases, higher ␣-and ␤-ENaC immunoreactivities on the basal surface of the ependyma may reflect a mechanism to attenuate the increase in tissue [Na ϩ ] by transporting Na ϩ out of tissue into the CSF. Further studies are needed to explore whether dysregulation of ENaC in the choroid plexus and/or ependyma contributes to sympathoexcitatory and pressor responses to a high-salt diet in Dahl S rats or SHR.
In conclusion, in Wistar rats, a chronic increase in CSF [Na ϩ ] by icv infusion of Na ϩ -rich aCSF increases expression of ␤-ENaC in the epithelial cells of the choroid plexus and ␣-and ␤-ENaC in the ependyma. In contrast, Na ϩ -rich aCSF has no effect on expression of ENaC subunits in the supraoptic nucleus, paraventricular nucleus, and subfornical organ. Spironolactone only prevents the increase in ␤-ENaC protein by Na ] may be one of the determinants for Na ϩ transport from the CSF into the choroid plexus and from brain tissue into the CSF.
